Diseases excluded from the analysis.

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Rieko Kondo (10010647) (author)
مؤلفون آخرون:	Shotaro Maeda (10817350) (author), Akira Kikuchi (202891) (author), Hiromichi Kiyono (3039834) (author), Tohru Sato (1420276) (author)
منشور في:	2022
الموضوعات:	Medicine Cell Biology Biotechnology Sociology Immunology Developmental Biology Science Policy Infectious Diseases Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified significant decrease immediately inhalation technique occur acting &# 946 41 &# 8211 29 &# 8211 26 &# 8211 exacerbation remained high continuous risk reduction ics )/ long another inhaled corticosteroid carefully monitored period asthma exacerbation compared inhaled corticosteroid carefully monitored another ics first exacerbation asthma exacerbation week interval week 32 week 20 switch compared sleep disorders significantly different significantly associated risk increased relative risk reasonable option odds ratio may 2014 least 4 earlier point confidence interval chronic rhinosinusitis asthma treated april 2019 approximately 4 70 ). 7 months 54 ). 4 weeks 2 agonist 04 ).
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة